NCT07438652 Effect of Mediterranean vs Paleolithic Diet on RA Activity, Sarcopenia and QOL: 12-Week RCT
| NCT ID | NCT07438652 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kasr El Aini Hospital |
| Condition | Rheumatoid Arthritis (RA) |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2026-01-17 |
| Primary Completion | 2026-06-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2026-01-17 with a primary completion date of 2026-06-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the effects of Mediterranean and Paleolithic dietary interventions on nutritional status, disease activity, fatigue, sleep, and quality of life in adults with rheumatoid arthritis (RA). Participants aged 40-60 years will be randomly assigned to follow either a Mediterranean diet, a Paleolithic diet, or continue their usual diet for 12 weeks. The study will assess anthropometric measurements, disease activity score (DAS28), laboratory biomarkers (CBC, CRP, ESR, lipid profile, fasting glucose, HbA1c), and patient-reported outcomes. The trial will determine whether these diets improve RA management and overall well-being.
Eligibility Criteria
Inclusion Criteria: * Patients classified as having rheumatoid arthritis according to the 2010 rheumatoid arthritis ACR/ EULAR classification criteria with a selected age group of 40 to 60 years old. Exclusion Criteria: * Patients with comorbidities (e.g., diabetes mellitus, hypertension, gout, thyroid dysfunction).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07438652 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 60 Years, studying Rheumatoid Arthritis (RA). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07438652 currently recruiting?
Yes, NCT07438652 is actively recruiting participants. Contact the research team at gehad.maghraby@kasralainy.edu.eg for enrollment information.
Where is the NCT07438652 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07438652 clinical trial?
NCT07438652 is sponsored by Kasr El Aini Hospital. The trial plans to enroll 75 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.